ArticleFrontiers in oncology2022

CCDC134 as a Prognostic-Related Biomarker in Breast Cancer Correlating With Immune Infiltrates.

Zhijian Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.